Skip to main content

Neuroscience

We are committed to researching and developing new, innovative, disease-modifying solutions to address some of the most difficult-to-treat neurologic diseases.

A resilient pursuit to preserve personhood

We are resolute in our commitment to help those living with and affected by the realities of neurologic diseases. We strive to preserve personhood in the face of unrelenting challenges. We stand with patients, their families and healthcare providers to navigate neuroscience’s unchartered frontiers and inevitable setbacks to deliver science that will make a meaningful difference and a remarkable impact on people’s lives.

Video still of older couple sitting on a couch

Living with a Neurologic Disease

The path toward transformational therapies

At AbbVie, we invest in neuroscience research that identifies opportunities to help people who live with neurologic disorders. We are advancing research and providing treatments across many neurologic disorders, including Alzheimer’s disease, bipolar disorder, bipolar depression, major depressive disorder, migraine, Parkinson’s disease, post-stroke spasticity, schizophrenia, stroke and other central nervous system disorders.

We are committed to investing in research that identifies opportunities for real modification, delivering pioneering science, built on inevitable setbacks, that will make a meaningful difference for patients.

Learn more about how we are empowering people living with migraine.

Neuroscience research centers opens in a new window

On May 18, 2016, we opened a 43,000-square-foot research center in Cambridge, Massachusetts. At the Cambridge Research Center, we undergo research to gain a deeper understanding of the biological mechanisms underlying neurodegenerative diseases.

Our focus areas

We are committed to helping those living with and affected by neurologic diseases, including Alzheimer’s disease, bipolar disorder, bipolar depression, major depressive disorder, migraine, Parkinson’s disease, post-stroke spasticity, and schizophrenia.

Delivering science that makes a difference

We invest in research that identifies opportunities for real modification – delivering science that will make a meaningful difference in people’s lives.

Related stories

How can we offer new hope for people with Parkinson’s disease?

The ongoing search for an answer sparked this doctor’s decades-long career in neurodegenerative disease research.